Preventing recurrent violent injury has always been an important component of public health approach to interpersonal violence. However, prior studies have done very little to highlight the true incidence of recurrent violent injury.
Preventing recurrent violent injury has always been an important component of public health approach to interpersonal violence. It has also been the prime focus of violence intervention programs. However, prior studies have done very little to highlight the true incidence of recurrent violent injury.
New research on recurrent violent injuries, its costs, and risk factors found that approximately 1 in 9 people sent to emergency rooms (ERs) for violent injuries in 2010 ended up being violently injured again within 2 years. The study was conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania and the findings are published in the American Journal of Emergency Medicine.
“While violence prevention programs in trauma centers have been shown to be effective, recurrent violent injury is still very common and very costly,” lead author Elinore Kaufman, MD, a resident in General Surgery at New York-Presbyterian/Weill Cornell Medical Center in New York, said in a statement. “We need to be doing more to make sure every patient has the resources they need to stay safe.”
Interpersonal violence led to more than 16,000 deaths, 140,000 hospitalizations, and 1.6 million ER visits in 2010, according to CDC. The medical costs for treating and preventing such incidences was an estimated $8.5 billion. While hospitals have focused on intervention programs to prevent recurrences among victims, the new research establishes more opportunities for intervention based on a statewide analysis.
Study Findings
The authors examined ER-reported injuries from interpersonal violence for Florida. All visits during 2010 and recurrent visits within 2 years were recorded. It was found that out of approximately 54,000 patients admitted to ERs for violent injuries in 2010, 11% returned with a new violent injury at least once within the next 2 years. At least 20% of these patients had 2 or more recurrences, with many injuries classifying as “severe.” These initial and recurrent ER visits amounted to a whopping $596 million in medical charges.
Other findings included:
Understanding the Risk Factors
Recurrent violent injury is a common and costly phenomenon. For effective violence prevention programs, understanding the risk factors could be the key.
Risk factors for recurrent violent injury included homelessness, residence in low income neighborhoods, and history of mental illness or alcohol abuse. Low income, homelessness, Medicaid or uninsurance, and black race were associated with increased odds of recurrence.
“These findings can serve as a baseline for interventions aimed at reducing recurrence,” Kaufman said. “Our findings also highlight the potential for housing stability, behavioral health and substance abuse programs to break cycles of violence.”
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More